Comparison Overview
Philips Pharma Solutions, formerly BioTel Research

Philips Pharma Solutions, formerly BioTel Research
155 Corporate Woods, Suite 180, Rochester, New York, US, 14623
Last Update: 03/04/2026
Philips Pharma Solutions, formerly BioTel Research, is a leading central core lab supporting clinical trials with products, services, and technologies for cardiac monitoring, medical imaging, and remote data capture. It was acquired by ICON plc in October 2023.

Hikma Pharmaceuticals
1 New Burlington Place, London, W1S 2HR, GB
Last Update: 03/04/2026
For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospita...
Compliance Ranges Comparison

Philips Pharma Solutions, formerly BioTel Research







Hikma Pharmaceuticals






Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Philips Pharma Solutions, formerly BioTel Research in 2026.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Hikma Pharmaceuticals in 2026.
Incident History - Philips Pharma Solutions, formerly BioTel Research (X = Date, Y = Severity)
Philips Pharma Solutions, formerly BioTel Research cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Hikma Pharmaceuticals (X = Date, Y = Severity)
Hikma Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

Philips Pharma Solutions, formerly BioTel Research

Hikma Pharmaceuticals
FAQ
Latest Global CVEs
Improper authorization in Microsoft Exchange Online allows an unauthorized attacker to disclose information over a network.
Authentication bypass by spoofing in Azure HorizonDB allows an unauthorized attacker to elevate privileges over a network.
Exposure of sensitive information to an unauthorized actor in Microsoft Graph allows an authorized attacker to disclose information over a network.
Improper neutralization of special elements in output used by a downstream component ('injection') in Copilot Chat (Microsoft Edge) allows an unauthorized attacker to disclose information over a network.
Improper neutralization of special elements used in a command ('command injection') in Microsoft Copilot allows an authorized attacker to execute code over a network.